Related Experiment Video
Updated: Jun 20, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Bone hydatid disease refractory to nitazoxanide treatment
Hans G Schipper1, Suat Simsek, Michiel A van Agtmael
1Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Amsterdam, The Netherlands. H.G.Schipper@amc.uva.nl
Abstract:
We report a patient with bone hydatid disease that was refractory to both long-term daily treatment with albendazole, combined with cimetidine or administered as monotherapy ( approximately 15 years) and a relatively short course of nitazoxanide combined with albendazole (3 months). Despite continuous daily medical treatment, bone invasion and destruction proceeded. His pain and disability progressively increased.
Related Concept Videos
Anthelminthic Agents
Amebiasis
Rocky Mountain Spotted Fever
Toxoplasmosis
Antiprotozoal Agents
Cryptococcal Meningitis

